國邦醫藥(605507.SH):子公司於12月24日開始有序復工復產
格隆匯12月24日丨國邦醫藥(605507.SH)公佈,隨着疫情防控形勢逐步好轉,浙江國邦、浙江東盈根據《杭州灣綜管辦轄區工業企業有序復工復產實施意見》、《紹興市上虞區化工生產企業復產操作方案》等文件要求於近日辦理了復工復產申請,並通過了主管部門的審批,公司於2021年12月24日開始有序復工復產。浙江國邦、浙江東盈將在確保疫情嚴格管控的前提下,有序實施復工復產,並根據疫情、政府指導及客户需求,及時調整生產經營計劃,挖掘現有產能生產能力,努力降低本次疫情的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.